Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)- 1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1292-1304

  Miyamoto, Masaomi ^a   Takahashi, Hideki ^a   Kato, Koki ^a   Hirai, Keisuke ^a   Ishihara, Yuji ^a   Goto, Giichi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DIAZEPAM; ETHYLCHOLINE MUSTARD AZIRIDINIUM; METHYLSCOPOLAMINE; SCOPOLAMINE; TACRINE; ZANEPEZIL;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; LEARNING DISORDER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; BRAIN; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LEARNING; MALE; MEMORY; RATS; RATS, WISTAR; TACRINE;

EID: 0030426815     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. AIGNER, T., MITCHELL, S. J., AGCLETON, J. P., DELONG, M. R., STRUBLE, R. G., PRICE, D. L., WENK, G. L. AND MISHKIN, M.: Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology 92: 292-300, 1987.
2. ANDREWS, J. S., JANSEN, J. H. M., LINDERS, S. AND PRINCEN, A.: Effects of disrupting the cholinergic system on short-term spatial memory in rata. Psychopharmacology 115: 485-494, 1994.
3. ANGLADE, F., BIZOT, J.-C., DODD, R. H., BAUDOIN, C. AND CHAPOUTHIER, G.: Opposite effects of cholinergic agents and benzodiazepine receptor ligands in a passive avoidance task in rats. Neurosci. Lett. 182: 247-250, 1994.
4. ASKEW, B. M.: A simple screening procedure for imipramine-like antidepressant agents. Life Sci. 10: 725-730, 1963.
5. BARTUS, R. T., DEAN, R. L. AND BEER, B.: Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics. Neurobiol. Aging 1: 145-152, 1980.
6. BARTUS, R. T., DEAN, R. L., BEER, B. AND LIPPA, A. S.: The cholinergic hypothesis of geriatric memory dysfunction. Science (Wash. DC) 217: 408-417, 1982.
7. BRITTON, K. T. AND KOOB, G. F.: Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement. Pharmacol. Biochem. Behav. 32: 967-970, 1989.
8. CHRISTIE, J. E., SHERING, A., FERGUSON, J. AND GLEN, A. I. M.: Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. Br. J. Psychiatry 138: 46-50, 1981.
9. CLARKE, R. P. F., ECCERSLEY, P. S., FRISBY, J. P. AND THORNTON, J. A.: The amnesic effect of diazepam (Valium). Br. J. Anaesth. 42: 690-697, 1970.
10. COLE, S. O.: Effects of benzodiazepines on acquisition and performance: A critical assessment. Neurosci. Biobehav. Rev. 10: 265-272, 1986.
11. CONSOLO, S., LADINSKY, H., PERI, G. AND GARATTINI, S.: Effect of diazepam on mouse whole brain and brain area acetylcholine and choline levels. Eur. J. Pharmacol. 27: 266-268, 1974.
12. COYLE, J. T., PRICE, D. L. AND DELONG, M. R.: Alzheimer's disease: A disorder of cortical cholinergic innervation. Science (Wash. DC) 219: 1184-1190, 1983.
13. DAVIS, K. L. AND MOHS, R. C.: Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am. J. Psychiatry 139: 1421-1424, 1982.
14. DAVIS, K. L., THAL, L. J., GAMZU, E. R., DAVIS, C. S., WOOLSON, R. F., GRACON, S. I., DRACHMAN, D. A., MORRIS, J. C., KAWAS, C. H., KNOPMAN, D. S., EARL, N. L., KUMAR, V., DOODY, R. S. AND TACRINE COLLABORATIVE STUDY GROUP.: A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer'e disease. N. Engl. J. Med. 327: 1253-1259, 1992.
15. DAVIS, P. AND MALONEY, A. J. F.: Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii: 1403, 1977.
16. DAWSON, G. R. AND IVERSEN, S. D.: The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav. Brain Res. 57: 143-153, 1993.
17. DRACHMAN, D. A.: Memory and cognitive function in man: Does the cholinergic system have a specific role? Neurology 27: 783-790, 1977.
18. DUNNETT, S. B.: Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 87: 357-363, 1985.
19. DUNNETT, S. B., EVENDEN, J. L. AND IVERSEN, S. D.: Delay-dependent short-term memory deficits in aged rats. Psychopharmacology 96: 174-180, 1988.
20. FARLOW, M., GRACON, S. I., HERSHEY, L. A., LEWIS, K. W., SADOWSKY, C. H. AND DOLAN-URENO, J.: A controlled trial of tacrine in Alzheimer's disease. JAMA 268: 2523-2529, 1992.
21. FINNEY, D. J.: Probit Analysis, Cambridge University, London, 1952.
22. FONNUM, F.: A rapid radiochemical method for the determination of choline acetyltransferase, J. Neurochem. 24: 407-409, 1975.
23. GAUTHIER, S., BOUCHARD, R., LAMONTAGNE, A., BAILEY, P., BERGMAN, H., RATNER, J., TESFAYE, Y., SAINT-MARTIN, M., BACHER, Y., CARRIER, L., CHARBONNEAU, R., CLARFIELD, A. M., COLLIER, B., DASTOOR, D., GAUTHIER, L., GERMAIN, M., KISSEL, C., KRIEGER, M., KUSHNIR, L., MASSON, H., MORIN, J., NAIR, V., NEIRINCK, L. AND SUISSA, S.: Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. N. Engl. J. Med. 322: 1272-1276, 1990.
24. GHONEIM, M. M. AND MEWALDT, S. P.: Benzodiazepines and human memory: A review. Anesthesiology 72: 926-938, 1990.
25. GOTTFRIES, C. G.: Alzheimer's disease and senile dementia: Biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245, 1985.
26. GRADY, C. L., GRIMES, A. M., PATRONAS, N., SUNDERLAND, T., FOSTER, N. L. AND RAPOPORT, S. I.: Divided attention, as measured by dichotic speech performance in dementia of the Alzheimer type. Arch. Neurol. 46: 317-320, 1989.
27. HATANAKA, H. AND TSUKUI, H.: Differential effects of nerve-growth factor and glioma conditioned medium on neurons cultured from various regions of fetal rat central nervous system. Dev. Brain Res. 30: 47-56, 1986.
28. HEIKKILA, R. E.: Differential effects of several dopamine uptake inhibitors and releasing agents on locomotor activity in normal and in reserpinized mice. Life Sci. 28: 1867-1873, 1981.
29. HIRAI, K., NAKAYAMA, T., MURAKOSHI, H., ISHIHARA, Y., GOTO, G. AND MIYAMOTO, M.: Characteristics of neuropharmacological effects of TAK-147, a novel acetylcholinesterase inhibitor, in vitro (Abstract). Soc. Neurosci. 19: 1812, 1993.
30. HODGES, H. AND GREEN, S.: Effects of chlordiazepoxide on cued radial maze performance in rats. Psychopharmacology 88: 460-466, 1986.
31. ISHIHARA, Y., HIRAI, K., MIYAMOTO, M. AND GOTO, G.: Central cholinergic agents. 6. Synthesis and evaluation of 3[1-(phenylmethyl)-4-piperidinyl)-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1- propanones and their analogs as central selective acetylcholinesterase inhibitors. J. Med. Chem. 37: 2292-2299, 1994.
32. JERRARD, L. E., KANT, G. J., MEYERHOFF, J. L. AND LEVY, A.: Behavioral and neurochemical effects of intraventricular AF64A administration in rats. Pharmacol. Biochem. Behav. 21: 272-280, 1984
33. JOHNSON, C. D. AND RUSSELL, R. L.: A rapid simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64: 229-238, 1975.
34. KATZMAN, R.: Alzheimer's disease. N. Engl. J. Med. 315: 964-973, 1986.
35. KLEINBERGER, N. AND YANAI, J.: Early phenobarbital-induced alterations in hippocampal acetylcholinesterase activity and behavior. Dev. Brain Res. 22: 113-123, 1985.
36. KNAPP, M. J., KNOPMAN, D. S., SOLOMON, P. R., PENDLEBURY, W. W., DAVIS, C. S. AND GRACON, S. L: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 271: 985-991, 1994.
37. MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T., HASEGAWA, T. AND NABESHIMA, T; Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647: 44-56, 1994.
38. MCGUIRE, P. S. AND SEIDEN, L. S.: The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats. J. Pharmacol. Exp. Ther. 214: 635-641, 1980a.
39. MCGUIRE, P. S. AND SEIDEN, L. S.: Differential effects of imipramine in rats as a function of DRL schedule value. Pharmacol. Biochem. Behav. 13: 691-694, 1980b.
40. MIYAMOTO, M., HIRAI, K., TAKAHASHI, H., KATO, K., NISHIYAMA, M., OKADA, H. AND NAGAOKA, A.: Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents. Eur. J. Pharmacol. 238: 181-189, 1993.
41. MIYAMOTO, M., KATO, J., NARUMI, S. AND NAGAOKA, A.: Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res. 419: 19-31, 1987.
42. MIYAMOTO, M., NARUMI, S. NAGAOKA, A. AND COYLE, J. T.: Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions. J. Pharmacol. Exp. Ther. 248: 825-835, 1989.
43. MOHS, R. C., DAVIS, B. M., JOHNS, C. A., MATHE, A. A., GREENWALD, B. S., HORVATH, T. B. AND DAVIS, K. L.: Oral physostigmine treatment of patients with Alzheimer's disease. Am. J. Psychiatry 142: 28-33, 1985.
44. MUIR, J. L., EVERITT, B. J. AND ROBBINS, T. W.: AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14: 2313-2326, 1994.
45. NABESHIMA, T., TOHYAMA, K., ICHIHARA, K. AND KAMEYAMA, T.: Effects of benzodiazepines on passive avoidance response and latent learning in mice: Relationship to benzodiazepine receptors and the cholinergic neuronal system. J. Pharmacol. Exp. Ther. 255: 789-794, 1990.
46. NAKAYAMA, T., TAKAHASHI, H., MIYAMOTO, M., GOTO, G. AND NAGAI, Y.: Beneficial effects of TAK-147, a novel acetylcholinesterase inhibitor, on cerebral energy metabolism and learning impairments in aged rats. Jpn. J. Pharmacol. 64: 156P, 1994.
47. O'DONNELL, J. M. AND SEIDEN, L. S.: Differential-reinforcement-of-low-rate 72-sec schedule: Selective effects of antidepressant drugs. J. Pharmacol. Exp. Ther. 224: 80-88, 1983.
48. PARASURAMAN, R. AND MARTIN, A.: Cognition in Alzheimer's disease: Disorders of attention and semantic knowledge. Curr. Opin. Neurobiol. 4, 237-244, 1994.
49. PELLEGRINO, L. J. AND CUSHMAN, A. J.: A Stereotaxic Atlas of the Rat Brain, Appleton-Century-Crofts, New York, 1967.
50. PERRY, E. K., CURTIS, M., PICK, D. J., CANDY, J. M., ATACK, J. R., BLOXHAM, C. A., BLESSED, G., FAIRBAIRN, A. W., TOMLINSON, B. E. AND PERRY, R. H.: Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparison with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 48: 413-421, 1985.
51. PERRY, E. K., TOMLINSON, B. E., BLESSED, G., BERGMANN, K., GIBSON, P. H. AND PERRY, R. H.: Correlation of cholinergic abnormalities with senile plaques and mental test scores. Br. Med. J. 2: 1457-1159, 1978.
52. PETERS, B. H. AND LEVIN, H. S.: Effects of physostigmine and lecithin on memory in Alzheimer's disease. Ann. Neurol. 6: 219-221, 1979.
53. PORSOLT, R. D., BERTIN, A. AND JALFRE, M.: Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharamacodyn. Ther. 229: 327-336, 1977.
54. PRICE, D. L., BORCHELT, D. R. AND SISODIA, S. S.: Alzheimer disease and the prion disorders amyloid β-protein and prion protein amyloidoses. Proc. Natl. Acad. Sci. U.S.A. 90: 6381-6384, 1993.
55. RUBIN, B., MALLONE, M. H., VAUGH, M. H. AND BURKE, J. C.: Bioassay of rauwolfia roots and alkaloids. J. Pharamacol. 120: 125-136, 1957.
56. SAHAKIAN, B. J., OWEN, A. M., MORANT, N. J., EAGER, S. A., BODDINGTON, S., CRAYTON, L., CROCKFORD, H. A., CROOKS, M., HILL, K. AND LEVY, R.: Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: Assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395-401, 1993.
57. SAHGAL, A.: Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats. Psychopharmacology 93: 243-249, 1987.
58. SCINTO, L. F. M., DAFFNER, K. R., CASTRO, L., WEINTRAUB, S., VAVRIK, M. AND MESULAM, M. M.: Impairment of spatially directed attention in patients with probable Alzheimer's disease as measured by eye movement. Arch. Neurol. 51: 682-688, 1994.
59. SELKOE, D. J.: Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17: 489-517, 1994.
60. SITARAM, N., WEINGARTNER, H. AND GILLIN, J. C.: Human serial learning: Enhancement with arecoline and impairment with scopolamine. Science (Wash. DC) 201: 274-276, 1978.
61. SKOOG, I.: The prevalence of psychotic, depressive and anxiety syndromes in demented and non-demented 85-year-olds. Int. J. Geriatr. Psychiatry 8: 247-253, 1993.
62. SOFFIE, M. AND LEJEUNE: Cholinergic blockade and response timing in rats. Psychopharmacology 106: 215-220, 1992.
63. SULSER, F., WATTS, J. AND BRODIE, B. B.: On the mechanism of antidepressant action of imipramine-like drugs. Ann. N. Y. Acad. Sci. 98: 279-288, 1962.
64. SUMMERS, W. K., MAJOVSKI, L. V., MARSH, G. M., TACHIKI, K. AND KLING, A.: Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315: 1241-1245, 1986.
65. TAN, S., KIRK, R. C., ABRAHAM, W. C., MCNAUGHTON, N.: Chlordiazepoxide reduces discriminability but not rate of forgetting in delayed conditional discrimination. Psychopharmacology 101: 550-554, 1990.
66. THIEBOT, M. H.: Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci. Biobehav. Rev. 9: 95-100, 1985.
67. TUETH, M. J.: How to manage depression and psychosis in Alzheimer's disease. Geriatrics 50: 43-49, 1995.
68. VAN HAAREN, F. AND VAN HEST, A.: The effects of scopolamine and methylscopolamine on visual and auditory discriminations in male and female Wistar rats. Pharmacol. Biochem. Behav. 32: 707-710, 1989.
69. VAN HAAREN, F., HEINSBROEK, R. P. W., LOUWERSE, A. AND VAN DE POLL, N. E.: d-Amphetamine differentially affects low, but not high response rates of male and female Wistar rats. Psychopharmacology 89: 73-76, 1986.
70. VAN HEST, A., STROET, J., VAN HAAREN, F. AND FEENSTRA, M.: Scopolamine differentially disrupts the behaviour of male and female Wistar rats in a delayed nonmatching to position procedure. Pharmacol. Biochem. Behav. 35: 903-909, 1990.
71. VAN HEST, A., VAN DRIMMELEN, M. AND OLIVIER, B.: Flesinoxan shows antidepressant activity in a DRL 72-s screen. Psychopharmacology 107: 474-479, 1992.
72. VIDA, S., DES. ROSIERS, P., CARRIER, L. AND GAUTHIER, S.: Prevalence of depression in Alzheimer's disease and validity of research diagnostic criteria. J. Geriatr. Psychiatry Neurol. 7: 238-244, 1994.
73. VOYTKO, M. L., OLTON, D. S., RICHARDSON, R. T., GORMAN, L. K., TOBIN, J. R. AND PRICE, D. L.: Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14: 167-186, 1994.
74. WENGER, G. R. AND WRIGHT, D. W.: Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol. Biochem. Behav. 36: 595-600, 1990.
75. WEINSTEIN, H. C., TEUNISSE, S. AND VAN GOOL, W. A.: Tetrahydroamino-acridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioral disturbances and burden experienced by carers. J. Neurol. 238: 34-38, 1991.
76. WHITEHOUSE, P. J., PRICE, D. L., STRUBLE, R. G., CLERK, A. W., COYLE, J. T. AND DELONG, M. R.: Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science (Wash. DC) 216: 1237-1239, 1982.
77. YAMAZAKI, M., MATSUOKA, N., MAEDA, N., KURATANI, K., OHKUBO, Y. AND YAMAGUCHI, I.: FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze. J. Pharmacol. Exp Ther. 272: 256-263, 1995.
78. YAMAZAKI, N., KATO, K., KURIHARA, E. AND NAGAOKA, A.: Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats. Psychopharmacology 103: 215-222, 1991.